Answers are grounded in this paper and cite their sources.
Senecavirus A (SVA) causes vesicular disease in pigs, creating a need for interventions that address viral replication and infection-associated injury. We evaluated purified d-α-tocopherol, a form of vitamin E (VE), in PK-15 cells and a mouse infection model. Virological and redox measurements were combined with glutathione (GSH) supplementation and depletion to assess antiviral activity and the contribution of host antioxidant responses. VE reduced both viral RNA abundance and infectious virus production in PK-15 cells. At 20 μM, the concentration with the greatest observed antiviral effect, VP1 RNA abundance decreased by approximately 87%, and infectious viral titre showed a 1.34-log 10 reduction. This antiviral response was accompanied by increased GSH content and glutathione peroxidase 4 (GPX4) expression and reduced indicators of oxidative injury. Ferrostatin-1 reduced viral replication alongside ferroptosis-associated biochemical changes. GSH supplementation reduced infectious virus production, whereas GSH depletion partially attenuated VE activity, supporting a contribution of GSH availability. In mice, 20 mg/kg VE administered 12 h after infection reduced relative SVA RNA abundance in all five tissues examined. Representative H&E-stained liver sections from mice receiving 20 mg/kg VE showed a hepatocyte arrangement more closely resembling that of the Mock group. VE restricts SVA replication in cultured porcine cells in association with improved GSH availability, increased GPX4 expression and attenuated ferroptosis-associated oxidative injury. The paired virological endpoints, GSH intervention results and mouse tissue observations support further evaluation of VE as a host-directed antiviral candidate against SVA.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: